ANL
Adlai Nortye Ltd.
NASDAQ · Healthcare · Biotechnology · KY
$15.01
+1.76%Margins
Gross margin
100.0%
EBITDA margin
-109.1%
EBIT margin
-113.3%
Net margin
-114.5%
FCF margin
-296.0%
-10.5%
Return on equity
-9.1%
Return on assets
-9.2%
Return on invested capital
0.08x
Asset turnover
-$58.0M
Cash from operations
$3.62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026